Joel Sunshine

Assistant Professor

Johns Hopkins University School of Medicine

United States

Research Interests

Explore related searches

Professors in United States Professors in Immunology Immunology professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Dr. Joel Sunshine is an Assistant Professor at Johns Hopkins School of Medicine in the United States. His research focuses on immunotherapy, tumor microenvironment engineering, and the development of novel gene delivery systems. Recent publications include studies on the response of hepatocellular carcinoma to immunotherapy, the effects of biomaterials on cancer cell behavior, and the evaluation of multiplex imaging techniques in pathologic assessment.

Articles (18)

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Year:

2020

Year:

UNITED STATES

View details

James Gordy

Johns Hopkins University

UNITED STATES

View details

Stephany Y Tzeng

Johns Hopkins University

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Joel Sunshine

Research Interests

Explore related searches

Contact this professor

About

Articles (18)

Immunotherapy response induces divergent tertiary lymphoid structure morphologies in hepatocellular carcinoma

Efficient Polymeric Nanoparticle Gene Delivery Enabled Via Tri- and Tetrafunctional Branching

Concordance of whole slide imaging and conventional light microscopy for assessment of pathologic response following neoadjuvant therapy for lung cancer

Highly-Multiplexed Immunofluorescence PhenoCycler Panel for Murine FFPE Yields Insight into Tumor Microenvironment Immunoengineering

Sex-dependent effects in the aged melanoma tumor microenvironment influence invasion and resistance to targeted therapy.

IFNα and 5-Aza-2'-deoxycytidine combined with a dendritic-cell targeting DNA vaccine alter tumor immune cell infiltration in the B16F10 melanoma model.

Biomaterial-Mediated Genetic Reprogramming of Merkel Cell Carcinoma and Melanoma Leads to Targeted Cancer Cell Killing <i>In Vitro</i> and <i>In Vivo</i>

Pembrolizumab-Induced Lichen Planus Pemphigoides in a Patient with Metastatic Adrenocortical Cancer: A Case Report and Literature Review.

Whole-Slide Imaging, Mutual Information Registration for Multiplex Immunohistochemistry and Immunofluorescence.

Disseminated Tuberculosis With an Atypical Cutaneous Manifestation in a Hematopoietic Cell Transplant Patient in the Early Posttransplant Period: Case Report and Review of the Literature.

High-throughput evaluation of polymeric nanoparticles for tissue-targeted gene expression using barcoded plasmid DNA.

A Series of RET Fusion Spitz Neoplasms With Plaque-Like Silhouette and Dyscohesive Nesting of Epithelioid Melanocytes

Clinical, morphologic, and genomic findings in ROS1 fusion Spitz neoplasms

BRAF fusion Spitz neoplasms; clinical morphological, and genomic findings in six cases

Melanocytic Neoplasms With MAP2K1 in Frame Deletions and Spitz Morphology

Postherpes zoster programmed death-1 inhibitor−associated zosteriform granulomatous reactions

Cutaneous Toxicities of PI3K Inhibitors: A Series of Two Cases and Review of the Literature

Successful Treatment of In-Transit Metastatic Melanoma in a Renal Transplant Patient With Combination T-VEC/Imiquimod Immunotherapy

Collaborators (7)

Alexander Girgis

Styliani Karanika

Jordan Green

Luciane Tsukamoto Kagohara

Hanfei Qi

James Gordy

Stephany Y Tzeng

Make your next move.